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Take home message: 
Hands can be vehicles for of transmission of pneumococcus leading to nasopharyngeal colonisation, 
even after drying.  
 
 
 
 
 
 
 
 
 
 
 
Background:  
Streptococcus pneumoniae (pneumococcus) is a major cause of acute otitis media, sinusitis, 
pneumonia and meningitis worldwide.[1] More than 1.2 million infant deaths are attributed to S. 
pneumoniae annually.[2] 
Colonisation of the human nasopharynx with pneumococcus is common, with prevalence between 
40-90% in children <5 years old and approximately 10% in adults in cross-sectional surveys.[3] 
Colonisation is important as it is a pre-requisite to infection, the primary reservoir for transmission, 
but can also boost immunity [1, 4] 
It is postulated that transmission of S. pneumoniae occurs primarily by indirect contact via inhalation 
of airborne droplets. Supporting this are observations that transmission is associated with higher 
density living (day care centres, prisons and nursing homes), and is enhanced by concurrent viral 
respiratory tract infections.[5] For upper respiratory tract infections in general, direct contact is 
implicated in disease transmission, which  can be interrupted by hand washing.[6] However, the 
relative contribution of direct and indirect transmission modes to pneumococcal colonisation and 
disease are unknown. We aimed to assess the potential for pneumococcal hand-to nose-transmission 
to cause nasopharyngeal colonisation. 
 
Methods:  
We enrolled 63 healthy adult participants, between April-May 2017, to our controlled Experimental 
Human Pneumococcal Challenge model (EHPC), modified slightly from previous published protocols 
to assess “hand-to-nose”. [7] 
Briefly, participants were administered pneumococcus (3.2x106 mid-log phase colony-forming units 
(CFU) of S. pneumoniae serotype 6B prepared as previously described) onto their fingertip or dorsum 
of their hand. [7] Bacterial density was confirmed by serial dilutions of the bacterial stock on blood 
agar (Oxoid). Participants were asked to either sniff the bacterial residue or to make direct contact 
with the nasal mucosal surface (pick/poke their nose), and to do so either immediately after exposure 
(‘wet’) or when visibly dry (approximately 1-2 minutes post-exposure). Baseline screening was 
undertaken prior to pneumococcal exposure; participants who were naturally colonised with 
pneumococcus were excluded prior to exposure. Pre-exposure throat swabs were also assayed for 
respiratory viruses (adenovirus, influenza A and B, coronavirus, respiratory syncytial virus/human 
metapneumovirus, rhinovirus and parainfluenza 1-4), using multiplex Polymerase Chain Reaction 
(PCR) as previously published.[8] 
All participants were followed up for 9 days post exposure. Nasopharyngeal colonisation was assessed 
in nasal washes collected at days 2, 6 and 9. Pneumococcal density in nasal washes was determined 
by culture in real time; serotype was determined as 6B using a latex agglutination kit (Statens Serum 
Institute, Denmark). Following completion of the study all samples were tested by quantitative PCR 
(qPCR) with primers for lytA, and for S. pneumoniae serotype 6A/B. Rates of pneumococcal acquisition 
between groups were compared using Fisher’s exact.   
All participants gave written, informed consent. Ethical permission was granted by the local National 
Health Service Research Ethics Committee (17/NW/0054). 
 
Results  
Between March and June 2017, 76 participants were recruited for the Hand to nose study (ISRCTN: 
12909224), with 63 participants completing all the study visits. The mean average age of volunteers 
was 22.6 years of age (range 18-45, median 21) and the male:female ratio was 23:40.  
Forty participants were initally randomly allocated to 4 different transmission groups; 1) sniffing wet 
bacterial suspension [‘wet sniff’] 2) sniffing bacterial suspension after air-drying [‘dry sniff’] 3) 
pick/poke nose with finger exposed to wet bacterial suspension [‘wet poke’] 4) pick/poke nose with 
finger exposed to bacterial suspension after air-drying [‘dry poke’].  
In this initial cohort of forty participants, eight (8/40, 20%) were found to be experimentally colonised 
with pneumococcus (6B) at follow up visits by culture, with highest rates in the ‘wet poke’ (4/10, 40%), 
and ‘wet sniff’ (3/10, 30%) groups. Allowing the bacteria to dry on the skin before “sniff” or “poke” 
led to 1/10 and 0/10 participants becoming colonised respectively (Figure 1). The 4 different groups 
were too small to compare, analysis of the wet versus dry groups highlighted that colonisation rates 
in the ‘wet’ group were significantly higher than the ‘dry’ group (P=0.04, Fisher exact test). 
Median post-exposure colonisation densities (CFU/ml nasal wash) of the ‘wet sniff’, ‘wet poke’ and 
‘dry sniff’ groups were 5.6x101 (range 4.3x10-1-3.7x106), 4.7 (range 4.5x10-1-1.3x102) and 2.4 (range 
1.2-9.6) respectively. Following the culture results the ‘wet sniff’ group was expanded to improve 
precision-estimates of rates, this group was expanded due to the combination of good colonisation 
rates and high density of colonisation episodes in participants. A total of 6/33 volunteers became 
colonised (18%). No viruses were detected in any throat swabs taken before pneumococcal exposure.  
Molecular detection (lytA qPCR) identified higher colonisation rates compared with culture (Whole 
cohort evaluated: 33/63 [52%] vs 13/63 [23%] respectively, P<0.0001, Fisher’s exact test). This was 
most apparent in ‘dry poke’ group; colonisation in 0/10 by culture and 7/10 using qPCR. Samples which 
were only positive with qPCR tended to have lower densities of carriage compared to samples positive 
with both methods. Higher densities were noted in the wet sniff group and in samples that were 
carriage positive with both methods.  
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Figure 1: A) Colonisation rates following classical culture of nasal wash samples at any time point after exposure in each 
transmission group. *No experimental carriers of strain 6B found in dry poke group but 2 participants became natural 
carriers of pneumococci after exposure to 6B. B) Comparison of culture (6A/B strain only) and lytA qPCR results for 
different transmission methods 
 
Discussion  
The study shows for the first time, using a controlled human infection model, that the hands can be a 
vehicle for transmission of pneumococcus and lead to acquisition of nasopharyngeal colonisation. 
This novel use of a human challenge model allowed for the study of pneumococcal transmission and 
colonisation in a controlled environment. Previous pneumococcal challenge studies have directly 
inoculated bacteria into the noses of participants. This direct exposure method with 6B serotype has 
resulted in a colonisation rate of approximately 45% using culture detection method [3, 4]. 
Colonisation rates in human challenge models are likely dependant on a variety of host and bacterial 
factors including host immunity. Lower colonisation rates in this study may be due to the sniffing 
transmission method causing movement of the pathogen out of the nasopharynx or due to death of 
pneumococcal bacteria during the drying process on the hands. 
Pneumococcal survival on the skin has been reported, with persistence of viable bacteria for 3 hours 
following exposure.[9] We have further shown that pneumococcus can survive drying on the skin, and 
go on to cause colonisation. An association between frequent sharing of drinking glasses or bottles 
and pneumococcal colonisation has also been reported [10]. The authors suggested that these findings 
indicate pneumococcal transmission through saliva is a highly plausible route in young adults however 
the possibility that the hands could be vectors for this transmission was not considered or 
investigated. Following the results of this study, it is plausible that hand contamination and hand-to-
nose transmission could be implicated in the higher rates of colonisation seen in the ‘frequently 
sharing group’. 
Our results support other studies in suggesting that determining pneumococcal colonisation by both 
culture and qPCR are complementary [11, 12]. Higher rates of detection using molecular methods 
likely represent superior sensitivity at low-density colonisation. Of those only detectable by qPCR, all 
had densities below 103 copies/ml.  The main limitation is the inability to distinguish viable from non-
viable bacteria, potentially causing false positive results. [3] 
Limitations of the study include the use of a young healthy adult population. Children are the primary 
reservoirs for community pneumococcal transmission, although an adult population was used in this 
study, the results suggest the potential for hand-to-nose transmission in paediatric populations.[2] 
The short follow up period of participants limits our ability assess how duration of colonisation and 
different transmission methods affect longevity of colonisation. The bacteria stock used for exposure 
is derived from culture media and is mid-log phase, these experimental conditions may influence 
pneumococcal viability and colonisation potential. Finally, we only investigated the potential 
transmission of pneumococcus by self-inoculation, examining relative risk of pneumococcal spread via 
aerosolised bacteria, direct contact or indirect contact would be beneficial similar to previous studies 
investigating transmission of respiratory viruses [13]. 
We were unable to investigate the relationship between colonisation acquisition and concurrent viral 
infection due to the absence of viral infection in our participants; likely due to seasonality. In a 
previous study asymptomatic co-infection increased odds of experimental pneumococcal colonisation 
(75% virus positive participants became colonised vs. 46% virus negative, P=0.02), and other 
experiments have shown that viruses (such as rhinovirus) facilitate acquisition and transmission 
between individuals. [8], [14] 
This study is the first to show that direct pneumococcal transmission can occur leading to colonisation 
acquisition. Good hand hygiene practices, already known to reduce enteric bacterial and viral disease, 
may also prevent the spread of bacteria thought to be primarily spread through aerosolisation. Follow-
on experimental trials would be needed to examine whether true person-to-person transmission 
could occur with pneumococcus moving from the hands into the nose efficiently enough to cause 
colonisation. This supports advice about cross-infection risk in patients with bronchiectasis from 
Chalmers et al [15]. Advising our high-risk patients to practice rigorous hand hygiene, to avoid shaking 
of hands and ensure basic infection control measures such as avoidance of sharing food, drink, mobile 
phones may reduce the transmission of respiratory bacterial pathogens such as pneumococcus. For 
healthy adults and children, it is unclear if reducing exposure to pneumococcus would be beneficial 
for overall health; pneumococcal exposure and colonisation have been shown to elicit immune 
responses which may be beneficial in later life [4, 16].   
Better understanding of the duration of survival of pneumococci in nasal secretions on the hands and 
the frequency of hand contamination would help understanding of the transmission process further. 
Improving knowledge about the process of pneumococcal shedding from the nose in humans during 
colonisation, and factors which promote shedding also warrants further study. This modification of 
the EHPC model has several potential uses including testing of current or new hand cleaning 
interventions to ensure reduction in transmission of this important bacterial pathogen. 
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